Sleep disturbance, neuro-immune markers, and depressive symptoms in older age: Conditional process analysis from the English Longitudinal Study of Aging (ELSA)

This study aimed to investigate the long-term association between subjective sleep disturbance and depressive symptoms in older adults, and ascertain whether this association is partially mediated by neuro-immune markers, while testing the moderation of sex using conditional process analyses, i.e.,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychoneuroendocrinology 2022-08, Vol.142, p.105770-105770, Article 105770
Hauptverfasser: Ballesio, Andrea, Zagaria, Andrea, Ottaviani, Cristina, Steptoe, Andrew, Lombardo, Caterina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 105770
container_issue
container_start_page 105770
container_title Psychoneuroendocrinology
container_volume 142
creator Ballesio, Andrea
Zagaria, Andrea
Ottaviani, Cristina
Steptoe, Andrew
Lombardo, Caterina
description This study aimed to investigate the long-term association between subjective sleep disturbance and depressive symptoms in older adults, and ascertain whether this association is partially mediated by neuro-immune markers, while testing the moderation of sex using conditional process analyses, i.e., combinations of mediation and moderation analyses. We analysed data of 2124 participants aged 50 and above from the English Longitudinal Study of Ageing (ELSA) across three waves of data collection. Sleep disturbance was assessed in 2008/9, serum levels of high sensitivity C-reactive protein (hs-CRP), insulin like growth factor-1 (IGF-1), white blood cell (WBC) count in 2012/2013, and self-reported depressive symptoms in 2016/2017. After accounting for health-related and psychosocial confounders, results showed that sleep disturbance significantly predicted depressive symptoms at follow-up in the whole sample and hs-CRP in women, but not in men. Hs-CRP also predicted depressive symptoms only in women. Moreover, hs-CRP significantly mediated the association between sleep disturbance and depressive symptoms in women, but not in men. The association between sleep disturbance and IFG-1was marginal, and the latter did not mediate the association between sleep and depressive symptoms neither in women nor in men. Results on WBC count were all non-significant. In conclusion, sleep disturbance resulted significantly associated with depressive symptoms in a long-term follow-up. Moreover, ELSA data provide preliminary evidence that increased inflammation may mediate this association in women. Future longitudinal studies may advance the knowledge in the field considering the mediating role of proinflammatory cytokines such as interleukin-6. •Pathophysiological mechanisms linking sleep disturbance to depression are largely unknown.•We examined the mediation role of several neuro-immune markers between sleep disturbance and depressive symptoms.•In sex-stratified models, higher hs-CRP mediated the association between sleep disturbance and depression only in women.•The mediation of hs-CRP remained significant after controlling for relevant health-related and psychosocial confounders.•There was no evidence of a mediation role of other neuro-immune markers including IGF-1 and white blood cell count.
doi_str_mv 10.1016/j.psyneuen.2022.105770
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2658647152</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0306453022001111</els_id><sourcerecordid>2658647152</sourcerecordid><originalsourceid>FETCH-LOGICAL-c298t-6d56665be3bafcbfedd2f61807a2df4bb190add9e518cd15e4502c5f2d399d833</originalsourceid><addsrcrecordid>eNqFkc9u1DAQhy0EotvCK1Q-FqlZ_Cd2Ek6sVktBWonDwtly7MnWS2IHO6mUp-FV8Wpbrpw8sr7fjD0fQreUrCmh8uNpPabFwwx-zQhj-VJUFXmFVrSueMG5JK_RinAii1JwcoWuUzoRQmQt2Vt0xUXZkLLmK_Tn0AOM2Lo0zbHV3sA9zm1jKNwwzB7woOMviOkea2-xhTFCSu4JcFqGcQpDws7j0FuIWB_hE94Gb93kgtc9HmMwmc5J3S_JJdzFMODpEfDOH3uXHvE--KObZuvO-CEXCw4d3hydP-K73f6w-fAOvel0n-D983mDfn7Z_dh-LfbfH75tN_vCsKaeCmmFlFK0wFvdmbYDa1knaU0qzWxXti1tiLa2AUFrY6mAUhBmRMcsbxpbc36D7i5986N_z5AmNbhkoO-1hzAnxaSoZVlRwTIqL6iJIaUInRqjy2taFCXqLEed1IscdZajLnJy8PZ5xtwOYP_FXmxk4PMFgPzTJwdRJeMgO7EugpmUDe5_M_4CaHineQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2658647152</pqid></control><display><type>article</type><title>Sleep disturbance, neuro-immune markers, and depressive symptoms in older age: Conditional process analysis from the English Longitudinal Study of Aging (ELSA)</title><source>Access via ScienceDirect (Elsevier)</source><creator>Ballesio, Andrea ; Zagaria, Andrea ; Ottaviani, Cristina ; Steptoe, Andrew ; Lombardo, Caterina</creator><creatorcontrib>Ballesio, Andrea ; Zagaria, Andrea ; Ottaviani, Cristina ; Steptoe, Andrew ; Lombardo, Caterina</creatorcontrib><description>This study aimed to investigate the long-term association between subjective sleep disturbance and depressive symptoms in older adults, and ascertain whether this association is partially mediated by neuro-immune markers, while testing the moderation of sex using conditional process analyses, i.e., combinations of mediation and moderation analyses. We analysed data of 2124 participants aged 50 and above from the English Longitudinal Study of Ageing (ELSA) across three waves of data collection. Sleep disturbance was assessed in 2008/9, serum levels of high sensitivity C-reactive protein (hs-CRP), insulin like growth factor-1 (IGF-1), white blood cell (WBC) count in 2012/2013, and self-reported depressive symptoms in 2016/2017. After accounting for health-related and psychosocial confounders, results showed that sleep disturbance significantly predicted depressive symptoms at follow-up in the whole sample and hs-CRP in women, but not in men. Hs-CRP also predicted depressive symptoms only in women. Moreover, hs-CRP significantly mediated the association between sleep disturbance and depressive symptoms in women, but not in men. The association between sleep disturbance and IFG-1was marginal, and the latter did not mediate the association between sleep and depressive symptoms neither in women nor in men. Results on WBC count were all non-significant. In conclusion, sleep disturbance resulted significantly associated with depressive symptoms in a long-term follow-up. Moreover, ELSA data provide preliminary evidence that increased inflammation may mediate this association in women. Future longitudinal studies may advance the knowledge in the field considering the mediating role of proinflammatory cytokines such as interleukin-6. •Pathophysiological mechanisms linking sleep disturbance to depression are largely unknown.•We examined the mediation role of several neuro-immune markers between sleep disturbance and depressive symptoms.•In sex-stratified models, higher hs-CRP mediated the association between sleep disturbance and depression only in women.•The mediation of hs-CRP remained significant after controlling for relevant health-related and psychosocial confounders.•There was no evidence of a mediation role of other neuro-immune markers including IGF-1 and white blood cell count.</description><identifier>ISSN: 0306-4530</identifier><identifier>EISSN: 1873-3360</identifier><identifier>DOI: 10.1016/j.psyneuen.2022.105770</identifier><identifier>PMID: 35490483</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Biomarkers ; Depression ; Inflammation ; Psychoimmunology ; Sleep</subject><ispartof>Psychoneuroendocrinology, 2022-08, Vol.142, p.105770-105770, Article 105770</ispartof><rights>2022 Elsevier Ltd</rights><rights>Copyright © 2022 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c298t-6d56665be3bafcbfedd2f61807a2df4bb190add9e518cd15e4502c5f2d399d833</citedby><cites>FETCH-LOGICAL-c298t-6d56665be3bafcbfedd2f61807a2df4bb190add9e518cd15e4502c5f2d399d833</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.psyneuen.2022.105770$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35490483$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ballesio, Andrea</creatorcontrib><creatorcontrib>Zagaria, Andrea</creatorcontrib><creatorcontrib>Ottaviani, Cristina</creatorcontrib><creatorcontrib>Steptoe, Andrew</creatorcontrib><creatorcontrib>Lombardo, Caterina</creatorcontrib><title>Sleep disturbance, neuro-immune markers, and depressive symptoms in older age: Conditional process analysis from the English Longitudinal Study of Aging (ELSA)</title><title>Psychoneuroendocrinology</title><addtitle>Psychoneuroendocrinology</addtitle><description>This study aimed to investigate the long-term association between subjective sleep disturbance and depressive symptoms in older adults, and ascertain whether this association is partially mediated by neuro-immune markers, while testing the moderation of sex using conditional process analyses, i.e., combinations of mediation and moderation analyses. We analysed data of 2124 participants aged 50 and above from the English Longitudinal Study of Ageing (ELSA) across three waves of data collection. Sleep disturbance was assessed in 2008/9, serum levels of high sensitivity C-reactive protein (hs-CRP), insulin like growth factor-1 (IGF-1), white blood cell (WBC) count in 2012/2013, and self-reported depressive symptoms in 2016/2017. After accounting for health-related and psychosocial confounders, results showed that sleep disturbance significantly predicted depressive symptoms at follow-up in the whole sample and hs-CRP in women, but not in men. Hs-CRP also predicted depressive symptoms only in women. Moreover, hs-CRP significantly mediated the association between sleep disturbance and depressive symptoms in women, but not in men. The association between sleep disturbance and IFG-1was marginal, and the latter did not mediate the association between sleep and depressive symptoms neither in women nor in men. Results on WBC count were all non-significant. In conclusion, sleep disturbance resulted significantly associated with depressive symptoms in a long-term follow-up. Moreover, ELSA data provide preliminary evidence that increased inflammation may mediate this association in women. Future longitudinal studies may advance the knowledge in the field considering the mediating role of proinflammatory cytokines such as interleukin-6. •Pathophysiological mechanisms linking sleep disturbance to depression are largely unknown.•We examined the mediation role of several neuro-immune markers between sleep disturbance and depressive symptoms.•In sex-stratified models, higher hs-CRP mediated the association between sleep disturbance and depression only in women.•The mediation of hs-CRP remained significant after controlling for relevant health-related and psychosocial confounders.•There was no evidence of a mediation role of other neuro-immune markers including IGF-1 and white blood cell count.</description><subject>Biomarkers</subject><subject>Depression</subject><subject>Inflammation</subject><subject>Psychoimmunology</subject><subject>Sleep</subject><issn>0306-4530</issn><issn>1873-3360</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkc9u1DAQhy0EotvCK1Q-FqlZ_Cd2Ek6sVktBWonDwtly7MnWS2IHO6mUp-FV8Wpbrpw8sr7fjD0fQreUrCmh8uNpPabFwwx-zQhj-VJUFXmFVrSueMG5JK_RinAii1JwcoWuUzoRQmQt2Vt0xUXZkLLmK_Tn0AOM2Lo0zbHV3sA9zm1jKNwwzB7woOMviOkea2-xhTFCSu4JcFqGcQpDws7j0FuIWB_hE94Gb93kgtc9HmMwmc5J3S_JJdzFMODpEfDOH3uXHvE--KObZuvO-CEXCw4d3hydP-K73f6w-fAOvel0n-D983mDfn7Z_dh-LfbfH75tN_vCsKaeCmmFlFK0wFvdmbYDa1knaU0qzWxXti1tiLa2AUFrY6mAUhBmRMcsbxpbc36D7i5986N_z5AmNbhkoO-1hzAnxaSoZVlRwTIqL6iJIaUInRqjy2taFCXqLEed1IscdZajLnJy8PZ5xtwOYP_FXmxk4PMFgPzTJwdRJeMgO7EugpmUDe5_M_4CaHineQ</recordid><startdate>20220801</startdate><enddate>20220801</enddate><creator>Ballesio, Andrea</creator><creator>Zagaria, Andrea</creator><creator>Ottaviani, Cristina</creator><creator>Steptoe, Andrew</creator><creator>Lombardo, Caterina</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220801</creationdate><title>Sleep disturbance, neuro-immune markers, and depressive symptoms in older age: Conditional process analysis from the English Longitudinal Study of Aging (ELSA)</title><author>Ballesio, Andrea ; Zagaria, Andrea ; Ottaviani, Cristina ; Steptoe, Andrew ; Lombardo, Caterina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c298t-6d56665be3bafcbfedd2f61807a2df4bb190add9e518cd15e4502c5f2d399d833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Biomarkers</topic><topic>Depression</topic><topic>Inflammation</topic><topic>Psychoimmunology</topic><topic>Sleep</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ballesio, Andrea</creatorcontrib><creatorcontrib>Zagaria, Andrea</creatorcontrib><creatorcontrib>Ottaviani, Cristina</creatorcontrib><creatorcontrib>Steptoe, Andrew</creatorcontrib><creatorcontrib>Lombardo, Caterina</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Psychoneuroendocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ballesio, Andrea</au><au>Zagaria, Andrea</au><au>Ottaviani, Cristina</au><au>Steptoe, Andrew</au><au>Lombardo, Caterina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sleep disturbance, neuro-immune markers, and depressive symptoms in older age: Conditional process analysis from the English Longitudinal Study of Aging (ELSA)</atitle><jtitle>Psychoneuroendocrinology</jtitle><addtitle>Psychoneuroendocrinology</addtitle><date>2022-08-01</date><risdate>2022</risdate><volume>142</volume><spage>105770</spage><epage>105770</epage><pages>105770-105770</pages><artnum>105770</artnum><issn>0306-4530</issn><eissn>1873-3360</eissn><abstract>This study aimed to investigate the long-term association between subjective sleep disturbance and depressive symptoms in older adults, and ascertain whether this association is partially mediated by neuro-immune markers, while testing the moderation of sex using conditional process analyses, i.e., combinations of mediation and moderation analyses. We analysed data of 2124 participants aged 50 and above from the English Longitudinal Study of Ageing (ELSA) across three waves of data collection. Sleep disturbance was assessed in 2008/9, serum levels of high sensitivity C-reactive protein (hs-CRP), insulin like growth factor-1 (IGF-1), white blood cell (WBC) count in 2012/2013, and self-reported depressive symptoms in 2016/2017. After accounting for health-related and psychosocial confounders, results showed that sleep disturbance significantly predicted depressive symptoms at follow-up in the whole sample and hs-CRP in women, but not in men. Hs-CRP also predicted depressive symptoms only in women. Moreover, hs-CRP significantly mediated the association between sleep disturbance and depressive symptoms in women, but not in men. The association between sleep disturbance and IFG-1was marginal, and the latter did not mediate the association between sleep and depressive symptoms neither in women nor in men. Results on WBC count were all non-significant. In conclusion, sleep disturbance resulted significantly associated with depressive symptoms in a long-term follow-up. Moreover, ELSA data provide preliminary evidence that increased inflammation may mediate this association in women. Future longitudinal studies may advance the knowledge in the field considering the mediating role of proinflammatory cytokines such as interleukin-6. •Pathophysiological mechanisms linking sleep disturbance to depression are largely unknown.•We examined the mediation role of several neuro-immune markers between sleep disturbance and depressive symptoms.•In sex-stratified models, higher hs-CRP mediated the association between sleep disturbance and depression only in women.•The mediation of hs-CRP remained significant after controlling for relevant health-related and psychosocial confounders.•There was no evidence of a mediation role of other neuro-immune markers including IGF-1 and white blood cell count.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>35490483</pmid><doi>10.1016/j.psyneuen.2022.105770</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0306-4530
ispartof Psychoneuroendocrinology, 2022-08, Vol.142, p.105770-105770, Article 105770
issn 0306-4530
1873-3360
language eng
recordid cdi_proquest_miscellaneous_2658647152
source Access via ScienceDirect (Elsevier)
subjects Biomarkers
Depression
Inflammation
Psychoimmunology
Sleep
title Sleep disturbance, neuro-immune markers, and depressive symptoms in older age: Conditional process analysis from the English Longitudinal Study of Aging (ELSA)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T09%3A17%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sleep%20disturbance,%20neuro-immune%20markers,%20and%20depressive%20symptoms%20in%20older%20age:%20Conditional%20process%20analysis%20from%20the%20English%20Longitudinal%20Study%20of%20Aging%20(ELSA)&rft.jtitle=Psychoneuroendocrinology&rft.au=Ballesio,%20Andrea&rft.date=2022-08-01&rft.volume=142&rft.spage=105770&rft.epage=105770&rft.pages=105770-105770&rft.artnum=105770&rft.issn=0306-4530&rft.eissn=1873-3360&rft_id=info:doi/10.1016/j.psyneuen.2022.105770&rft_dat=%3Cproquest_cross%3E2658647152%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2658647152&rft_id=info:pmid/35490483&rft_els_id=S0306453022001111&rfr_iscdi=true